BMY - Bristol-Myers Squibb
This page shows which of the focused investors we track hold BMY and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2014 it was held by 7 managers with an aggregate reported value of $39.39M, which is 0.01% of the combined portfolio.
As of Q2 2014, 7 tracked institutional managers held BMY (Bristol-Myers Squibb) with an aggregate reported value of $39.39M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BMY — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2014
- Ticker
- BMY
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Mairs & Power Growth Fund - Mairs & Power Growth Fund | 0.20% | Reduce -1.1% | 293,539 | $14.24M |
| 2 | Muhlenkamp - Muhlenkamp | 1.82% | Add +0.4% | 212,770 | $10.32M |
| 3 | Valley Forge Capital Management - Valley Forge Capital Management | 0.88% | Reduce -6.1% | 168,990 | $8.2M |
| 4 | Dodge & Cox - Dodge & Cox | 0.00% | Reduce -0.3% | 78,921 | $3.83M |
| 5 | Kahn Brothers Group - Kahn Brothers Group | 0.20% | Reduce -6.8% | 27,650 | $1.34M |
| 6 | Bill Nygren - Oakmark Funds | 0.00% | Reduce -27.8% | 15,600 | $757K |
| 7 | First Eagle - First Eagle Investment Management | 0.00% | Reduce -12.3% | 14,492 | $703K |
Loading holder history for BMY…